Washington: A simple drug regimen of two anti-clotting drugs - clopidogrel and aspirin - can lower the risk of suffering a stroke by about one-third, a new clinical trial has showed.The clinical trial involved 5,170 people, who were hospitalized after suffering minor ischemic strokes or stroke-like events known as transient ischemic attacks, or TIAs, in which blood flow to the brain is briefly blocked, and was conducted at multiple sites in China and designed in partnership with a physician at UC San Francisco.Then all patients were randomized into two groups and treated for three months with aspirin alone or aspirin plus clopidogrel, which is marketed as Plavix. The three-month period following stroke is considered the most critical for medical intervention.
Appointment of IPS Archana challenged; hearing in SC tomorrow
Railway recruitment board paper leaked in Lucknow, two held
Pune blast: ATS to question Indian Mujahideen terrorists in custody
UPSC aspirants protest outside Rajnath Singh`s residence